Loading...
01/09 22:53
Loading...
Medtronic PLC (MDT) is set to release its FY2026Q2 earnings performance on 11/18 05:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 8.86B and an earnings per share (EPS) of 1.31 for the FY2026Q2. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings forecast predicts a "Beat" performance driven by revenue growth from new product approvals and operational efficiencies, though tempered by some margin pressures.
Fact Data Analysis:
CMS Coverage for Renal Denervation (October 2025): Medicare coverage for Symplicity Spyral (Cardiovascular segment) opens a large addressable market for uncontrolled hypertension treatment, likely driving near-term adoption.
FDA Approvals: Clearance for Altaviva (Neuromodulation) and MiniMed 780G for Type 2 diabetes (Diabetes segment) expands revenue opportunities in key growth areas.
Hugo Robotic System Milestones: Successful hernia repair study results (MedSurg) and U.S. IDE trial launch for gynecology procedures position Hugo as a growth driver.
Operational Efficiency: Stifel noted Hugo’s supply chain readiness for U.S. launch, which could reduce costs and improve margins.
Strategic Collaboration with Orchestra BioMed: Sustained blood pressure reductions from AVIM therapy (Cardiovascular) may accelerate adoption, boosting revenue without significant R&D reinvestment.
Integer’s Depressed 2026 Outlook: Uncertainty around demand for two electrophysiology products (potentially linked to Medtronic’s CAS segment) creates downside risk. Wells Fargo downplays this, but supply chain disruptions could impact growth.
Mixed Margin Signals: While cost initiatives are in place, business mix shifts (e.g., Hugo rollout costs) may delay gross margin stabilization.
Directional Play:
Hedging:
Catalyst Watch:
The earnings call summary reveals positive financial performance with growth in key segments and improved margins. Despite some declines, overall growth in revenue and EPS exceeded expectations. The Q&A section highlights management's confidence in product launches and strategic investments, though some details were vague. The raised guidance and strong pipeline, particularly in cardiovascular and neuroscience, indicate positive sentiment. The combination of these factors suggests a positive stock price movement over the next two weeks.
Medtronic PLC (MDT) is scheduled to release its FY2026Q2 earnings report onNov 18, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 8.86B in revenue and an EPS of 1.31 for Medtronic PLC's FY2026Q2.
Intellectia's exclusive AI algorithms forecast a Beat forMedtronic PLC's FY2026Q2 earnings, with a prediction date of Nov 18, 2025. Medtronic PLC The earnings forecast predicts a "Beat" performance driven by revenue growth from new product approvals and operational efficiencies, though tempered by some margin pressures.
Leverage Intellectia's AI forecast to position trades ahead of theNov 18, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!
